Naomi Serling-Boyd

15PUBLICATIONS
56CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersSensory systemsPacific Peoples theory of change models for healthInfectious diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 12, 2026
B-Cell Depletion Relative to Tumor Necrosis Factor Inhibition Extends the Duration of Viral Shedding in COVID-19 Among Autoimmune Disease Patients: A Matched Prospective Cohort Study.

|Jul 16, 2026
Association of oral outpatient antiviral medications for COVID-19 with the risk of post-acute sequelae of COVID-19 at 28 and 90 days in a cohort of individuals with systemic autoimmune rheumatic diseases.

|Apr 27, 2026
Differences in SARS-CoV-2 Antigen Persistence in Individuals With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A RECOVER-Adult Cohort Study.

|Nov 01, 2025
Ongoing Benefits of SARS-CoV-2 Vaccination and Booster Vaccination 5 Years Following the Start of the COVID-19 Pandemic.

Avira Som, Naomi J Patel

|Mar 05, 2025
Patients with systemic autoimmune rheumatic diseases remain at risk for hospitalisation for COVID-19 infection in the Omicron era (2022-2024): a retrospective cohort study.

Naomi J Patel, Shruthi Srivatsan, Emily N Kowalski

|Mar 01, 2024
Factors Associated With an Electronic Health Record-Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease.

Naomi J Patel, Xiaosong Wang, Miao Lin

Pageof 3

Frequent Collaborators

11 joint publications

Zachary Wallace

10 joint publications

Jeffrey A Sparks

3 joint publications

Pedro M Machado

3 joint publications

Kathleen M Vanni